Merck & Co Digital Transformation Strategy Analysis Report 2025: Accelerators, Innovation Programs, Incubators, ICT, Technology Initiatives, Partnerships, Investments, Acquisitions, Network Map

Merck's market opportunities lie in its broad biopharmaceutical offerings, targeting oncology, vaccines, and more, alongside extensive veterinary solutions. Its tech-driven innovations, strategic partnerships, and global presence enhance its competitive edge in healthcare and digital transformation initiatives.


Dublin, Feb. 25, 2026 (GLOBE NEWSWIRE) -- The "Enterprise Tech Ecosystem Series: Merck & Co., Inc. 2025" company profile has been added to ResearchAndMarkets.com's offering.

The report provides insights into company's tech activities, including its digital transformation strategies, its innovation programs, and its technology initiatives.

Merck & Co Inc (Merck) is a biopharmaceutical company that discovers, develops, manufactures, and markets medicines, vaccines, biologic therapies, and animal health products.

The company offers prescription medicines under the therapy areas of oncology, vaccines, infectious diseases, cardio-metabolic disorders, immunology, neuroscience, and ophthalmology. It also offers a wide range of veterinary pharmaceuticals; vaccines; health management solutions and services; and identification, traceability, and monitoring products.

Merck's products are provided to drug wholesalers, retailers, hospitals, government agencies, health maintenance organizations, pharmacy benefit managers, other institutions, veterinarians, distributors, animal producers, farmers, and pet owners. It operates manufacturing facilities in North America, South America, Western Europe, Africa, and Asia. Merck is headquartered in Rahway, New Jersey, the US.

The report provides information and insights into Merck's tech activities, including:

  • Insights of its digital transformation strategies and innovation programs.
  • Overview of technology initiatives covering partnerships, product launches, investments, and acquisitions.
  • Insights on each technology initiative including technology theme, objective, and benefits.
  • Details of estimated ICT budgets and major ICT contracts.

Reasons to Buy

  • Gain insights into Merck's tech operations.
  • Gain insights into its tech strategies and innovation initiatives.
  • Gain insights into its technology themes under focus.
  • Gain insights into various product launches, partnerships, investments, and acquisitions.

Key Topics Covered:

  • Merck's Overview
  • Merck's Digital Transformation Strategy
  • Merck's Accelerators, Incubators, and Innovation Programs
  • Merck's Technology Focus
  • Merck's Technology Initiatives
  • Merck's Venture Arm
  • Merck's Investments
  • Merck's Acquisitions
  • Merck's Tech Ecosystem
  • Merck's ICT Budget & Contracts
  • Merck's Senior Management Team
  • Our Thematic Scorecard for the Pharmaceuticals and Healthcare Sector

Companies Featured

  • McKinsey & Company
  • Boston Consulting Group
  • Unnatural Products
  • Variational AI
  • Vector Institute
  • D4H
  • Amazon
  • Evaxion Biotech
  • Mila
  • Owkin
  • Saama
  • Absci
  • Hyfe
  • Philips
  • Natera
  • Evidation
  • Syapse
  • Corning
  • Seeq
  • SAP
  • IBM
  • KPMG
  • Walmart
  • Google Cloud
  • Veeva Systems
  • Appian

For more information about this company profile visit https://www.researchandmarkets.com/r/b96loe

About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

 

Mot-clé


Coordonnées

GlobeNewswire